Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis
about
Animal models of systemic sclerosis: their utility and limitations.Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblastsCaveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species.Methyl-β-cyclodextrin up-regulates collagen I expression in chronologically-aged skin via its anti-caveolin-1 activityCaveolin-1, cellular senescence and age-related diseases.Loss of caveolin-1 alters extracellular matrix protein expression and ductal architecture in murine mammary glandsInteraction of caveolin-1 with ATG12-ATG5 system suppresses autophagy in lung epithelial cells.Metabolic fingerprints of human primary endothelial and fibroblast cellsInterstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update.Autophagy: controlling cell fate in rheumatic diseases.Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?Autophagy and mesenchymal cell fibrogenesis.Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.Autophagy is a key feature in the pathogenesis of systemic sclerosis.Development and progression of immobilization-induced skin fibrosis through overexpression of transforming growth factor-ß1 and hypoxic conditions in a rat knee joint contracture model.Metabolomic profile of systemic sclerosis patients.
P2860
Q28390528-4B9C5891-BE6B-4E82-8F9D-20D6312CDE05Q34000514-D1CA71B9-7867-45BA-87A2-8619C46F841FQ34495667-00943C30-1B04-41B8-8F18-4AC9754D029DQ35273298-EFCA1D18-3719-4E71-8067-2809CFAADA78Q35626889-B5FE2829-C0C0-4496-AA00-8CC3EADD36F7Q36276995-18F77320-F1EA-4FA7-B92F-B4DD5A4A8B65Q36563999-348E1C2B-4CEC-4B8C-A27E-0A90FD9E72D1Q36952522-A3B07F4F-C952-4B19-9B8E-45C4CB8DBF02Q38065960-9A8EC7DD-29A9-4A5F-A7F5-1AAABE7691CFQ38873681-5A8C5F36-F5A6-4B9D-A838-36B7B167D092Q39173742-34CF044B-EEAA-478A-A3A5-6A33E5DBB450Q39319936-4620CD76-7947-46F3-80C3-83994CC8DB29Q50884558-E84B2C95-2F63-45AC-A78A-DBE4A8369706Q51215761-816C03A9-EFE9-4557-A17F-470F07C76BFDQ52798918-8F5296A2-1B65-4CCE-9C2D-E0C4D33532D9Q55191669-4C942015-A0C2-46FC-B0FF-5360E30D95B6
P2860
Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@ast
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@en
type
label
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@ast
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@en
prefLabel
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@ast
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@en
P2093
P2860
P50
P356
P1433
P1476
Scleroderma-like properties of ...... ibrosis and systemic sclerosis
@en
P2093
Alex Molchansky
David P Beason
George Purkins
Louis J Soslowsky
Remedios Castello-Cros
Renato V Iozzo
P2860
P304
P356
10.4161/CC.10.13.16227
P577
2011-07-01T00:00:00Z